Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Nonsense Mutations in the lsa-Like Gene in Enterococcus faecalis Isolates Susceptible to Lincosamides and Streptogramins A

Julia Dina, Brigitte Malbruny, Roland Leclercq
Julia Dina
Service de Microbiologie, CHU Côte de Nacre, 14033 Caen Cedex, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brigitte Malbruny
Service de Microbiologie, CHU Côte de Nacre, 14033 Caen Cedex, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Leclercq
Service de Microbiologie, CHU Côte de Nacre, 14033 Caen Cedex, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: leclercq-r@chu-caen.fr
DOI: 10.1128/AAC.47.7.2307-2309.2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The lsa gene confers intrinsic resistance to lincosamides and streptogramins A in Enterococcus faecalis, probably by active efflux. The lsa-like genes of two clinical isolates of E. faecalis susceptible to lincosamides and dalfopristin contained mutations that produced premature termination codons. Revertant mutants were obtained by selection on agar plates containing clindamycin.

Resistance to lincosamides (lincomycin and clindamycin) and streptogramins A (dalfopristin, pristinamycin II, and virginiamycin M) that defines the LSA phenotype is intrinsic in Enterococcus faecalis. Resistance to factor A of streptogramins is responsible for the loss of synergism between factors A and B composing the streptogramin mixture (quinupristin-dalfopristin, pristinamycin, and virginiamycin) that explains the intrinsic resistance of E. faecalis to this class of antibiotics (3, 7). Recently, this resistance has been related to the expression of a chromosomal lsa gene in E. faecalis OG1RF, which appears to be species specific (11). Inactivation of the lsa gene resulted in susceptibility to clindamycin, dalfopristin, and quinupristin-dalfopristin, whereas complementation with a recombinant plasmid bearing an intact lsa gene restored resistance to clindamycin and dalfopristin (11). The Lsa protein shows similarities to members of a superfamily of transport-related proteins known as ABC transporters. ABC proteins are capable of transporting both small and large molecules in response to ATP hydrolysis. Several characterized or postulated ABC transporters have been reported in staphylococci and enterococci to export antimicrobials belonging to the macrolide-lincosamide-streptogramin family (1, 9, 10). The ABC transporter system requires two ATP-binding domains located in the cytoplasm that interact with two hydrophobic domains consisting generally in six transmembrane segments. The four core components of an ABC transporter can be synthesized as individual proteins or be fused into multifunctional polypeptides in a variety of combinations (6). Conserved motifs that are used to define ABC domains have been identified in Lsa, i.e., the Walker A and B motifs, which are involved in the binding and hydrolysis of ATP, and an ABC signature probably involved in energy transduction (6). Similar to the MsrA protein putatively responsible for macrolide efflux, the two ATP-binding regions of Lsa are fused into a single protein (9). However, no transmembrane partner has been found associated with the Lsa protein and the efflux mechanism has not been proven. The mechanism of resistance to lincosamides and streptogramins A therefore remains incompletely elucidated.

Clinical isolates of E. faecalis susceptible to lincosamides and streptogramins A.

Strains of E. faecalis UCN32 and UCN33 were isolated from urine samples. The isolates were identified as E. faecalis by API 20Strep (Biomérieux, Marcy l'Etoile, France) and conventional techniques (5). Antimicrobial susceptibility testing by the agar diffusion technique showed that the isolates were susceptible to ampicillin and low levels of gentamicin, and erythromycin and were surprisingly susceptible to clindamycin, lincomycin, and quinupristin-dalfopristin. Determination of MICs of clindamycin, lincomycin, and dalfopristin by the agar dilution technique (http://www.sfm.asso.fr ) confirmed the susceptibility to these antimicrobials, which was unusual for E. faecalis isolates (Table 1). Since certain enterococcal species such as Enterococcus faecium, Enterococcus durans, and Enterococcus hirae do not display the intrinsic LSA resistance phenotype (2), identification of the isolates was questioned. However, identification of the isolates as E. faecalis was confirmed by amplification of a DNA fragment of the expected size, using primers specific for the ddl gene of E. faecalis (encoding a chromosomal d-alanyl-d-alanine ligase) (4).

View this table:
  • View inline
  • View popup
TABLE 1.

MICs of erythromycin, lincosamides, and streptogramins for E. faecalis strains

Sequence of the lsa-like gene of isolates.

The analysis of the sequence of the lsa gene of E. faecalis V583, obtained from The Institute for Genomic Research website at http://www.tigr.org , allowed us to design four pairs of primers to amplify overlapping DNA fragments (Table 2). A DNA region of E. faecalis UCN32 and UCN33 and of the reference strain E. faecalis ATCC29212 (resistant to lincosamides and streptogramins A) that included the entire lsa-like gene and 436 nucleotides upstream was sequenced in both directions. The predicted Lsa sequences of E. faecalis ATCC 29212 (GenBank access no. AY225127) and E. faecalis V583 were nearly identical except for five substitutions (Fig. 1). In E. faecalis UCN32, in addition to a few substitutions, deletion of an adenine was detected at position 618 (base relative to ATG), which generated a stop codon four nucleotides downstream. In E. faecalis UCN33, a G-T mutation at position 987 produced a stop codon. For both strains, the mutations would lead to a premature termination of the LSA sequence before the second Walker A motif for E. faecalis UCN32 and before the second Walker B motif for E. faecalis UCN33 (Fig. 1). Our work suggested that the loss of only the second Walker B motif was deleterious to the function of LSA.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Multiple-sequence alignment of deduced amino acid sequences of the lsa-like genes from E. faecalis V583, ATCC 29212, UCN32, and UCN33. ClustalW at the Infobiogen website (http://www.infobiogen.fr ) was used. The two ATP-binding domains consisting of Walker A (WA) and Walker B (WB) motifs (marked in solid black) and of a signature (SGG) sequence (underlined) are shown. Asterisks indicate differences in the amino acids.

View this table:
  • View inline
  • View popup
TABLE 2.

Oligonucleotides used for amplification of lsa-like genes

Selection of revertant mutants.

Approximately 108 cells of E. faecalis UCN32 and E. faecalis UCN33 were spread onto brain heart infusion agar plates containing 20 μg of clindamycin/ml and were incubated for 24 h at 37°C. Resistant mutants were obtained at frequencies approximately equal to 10−6. Three mutants derived from each parental strain were selected and were further studied. All displayed an LSA phenotype (coresistance to clindamycin, lincomycin, and dalfopristin) (Table 1). lsa sequence analysis in the three mutants, UCN32-1, UCN32-2, and UCN32-3, derived from E. faecalis UCN32 showed an insertion of an adenine in place of the deletion in the parent strain, which restored a sequence identical to that of E. faecalis V583. In the mutants from E. faecalis UCN33, the stop codon (TAA) was changed to a glutamic acid codon (GAA) in mutant UCN33-1 or to a glutamine codon (CAA) in mutants UCN33-2 and UCN33-3. There were no differences between the MICs of lincosamides and dalfopristin for mutants (Table 1).

This study confirms that the lsa gene was responsible for intrinsic resistance to lincosamides and streptogramins A in E. faecalis. It also shows that clindamycin resistance is not always reliable as an identification marker of E. faecalis. Since revertant mutants resistant to clindamycin were readily obtained in the presence of this antimicrobial, the use of clindamycin should be discouraged in the case of infection by clindamycin-susceptible E. faecalis.

FOOTNOTES

    • Received 30 January 2003.
    • Accepted 21 March 2003.
  • Copyright © 2003 American Society for Microbiology

REFERENCES

  1. 1.↵
    Allignet, J., V. Loncle, and N. El Sohl. 1992. Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics. Gene117:45-51.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Bozdogan, B., and R. Leclercq. 1999. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob. Agents Chemother.43:2720-2725.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Duh, R. W., K. V. Singh, K. Malathum, and B. E. Murray. 2001. In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification. Microb. Drug Resist.7:39-46.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Dutka-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol.33:24-27.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Facklam, R. R., and M. D. Collins. 1989. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol.27:731-734.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Linton, K. J., and C. F. Higgins. 1998. The Escherichia coli ATP-binding cassette (ABC) proteins. Mol. Microbiol.28:5-13.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Maskell, J. P., A. M. Sefton, J. Yong, S. J. Chi, and J. D. Williams. 1988. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin. Infection16:365-370.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.
    Ross, J. I., E. A. Eady, J. H. Cove, and S. Baumberg. 1996. Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene183:143-148.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Ross, J. I., E. A. Eady, J. H. Cove, W. J. Cunliffe, S. Baumberg, and J. C. Wootton. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol.4:1207-1214.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Singh, K. V., K. Malathum, and B. E. Murray. 2001. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob. Agents Chemother.45:263-266.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Singh, K. V., G. M. Weinstock, and B. E. Murray. 2002. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob. Agents Chemother.46:1845-1850.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Nonsense Mutations in the lsa-Like Gene in Enterococcus faecalis Isolates Susceptible to Lincosamides and Streptogramins A
Julia Dina, Brigitte Malbruny, Roland Leclercq
Antimicrobial Agents and Chemotherapy Jul 2003, 47 (7) 2307-2309; DOI: 10.1128/AAC.47.7.2307-2309.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Nonsense Mutations in the lsa-Like Gene in Enterococcus faecalis Isolates Susceptible to Lincosamides and Streptogramins A
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Nonsense Mutations in the lsa-Like Gene in Enterococcus faecalis Isolates Susceptible to Lincosamides and Streptogramins A
Julia Dina, Brigitte Malbruny, Roland Leclercq
Antimicrobial Agents and Chemotherapy Jul 2003, 47 (7) 2307-2309; DOI: 10.1128/AAC.47.7.2307-2309.2003
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • Clinical isolates of E. faecalis susceptible to lincosamides and streptogramins A.
    • Sequence of the lsa-like gene of isolates.
    • Selection of revertant mutants.
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Codon, Nonsense
Enterococcus faecalis
macrolides
Streptogramin A

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596